Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2011-05-03
2011-05-03
Stucker, Jeffrey (Department: 1649)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S133100, C424S178100, C514S017700
Reexamination Certificate
active
07935339
ABSTRACT:
The present invention relates to the use of inhibitors of the CD95 ligand/receptor system for the manufacture of a medicament for the treatment of neurological disorders or injuries in a mammal, particularly for the treatment of spinal cord injury, more particularly for the treatment of paraplegia.
REFERENCES:
patent: 6001962 (1999-12-01), Ramer et al.
patent: 2003/0082180 (2003-05-01), Krammer et al.
patent: 2003/0109416 (2003-06-01), Nagata et al.
patent: 2004/0014176 (2004-01-01), Ashkenzai et al.
patent: 2004/0053920 (2004-03-01), Bebbington et al.
patent: 0 842 948 (1998-05-01), None
patent: 0 992 243 (2000-04-01), None
patent: WO 95/27735 (1995-10-01), None
patent: WO 99/14330 (1999-03-01), None
patent: WO 00/58466 (2000-10-01), None
patent: WO 01/41803 (2001-06-01), None
patent: WO 01/72707 (2001-10-01), None
Martin-Villalba et al. Cell Death and Differentiation, vol. 8, 2001, pp. 679-686.
Mehmet. Cell Death and Differentiation, vol. 8, 2001, pp. 659-661.
Eves et al. J. Neurosci., vol. 21, 2001, pp. 4996-5006.
Raoul et al. J. Cell Biology, vol. 147, 1999, pp. 1049-1061.
Raoul et al. Current Opinion in Neurobiology, vol. 10, 2000, pp. 111-117.
Martin-Villalba et al., J. Neurosci., vol. 19, 1999, pp. 3809-3817.
Sakurai et al., Brain Res., vol. 797, 1998, pp. 23-28.
M. Zurita et al: “Presence and Significance of CD-95 (FAS/AP01) Expression After Spinal Cord Injury.” Journal of Neurosurgery, vol. 94; No. 2 suppl., Apr. 2001.
I. Herr et al: “Activation of CD95 (AP0-1/FAS) Signaling by Ceramide Mediates Cancer Therapy-Induced Apoptosis.” The EMBO Journal, vol. 16, No. 20, Oct. 15, 1997.
D. Perez et al: “E1B 19K Inhibits FAS-Mediated Apoptosis Through FADD-Dependent Sequestration of Flice.” The Journal of Cell Biology, vol. 141, No. 5, Jun. 1, 1998.
E. Bradbury et al: “Chondroitinase ABC Promotes Functional Recovery After Spinal Cord Injury.” Nature, vol. 416, Apr. 11, 2002, pp. 636-640.
Demjen Deana
Krammer Peter
Martin-Villalba Ana
Deutsches Krebsforschungszentrum Stiftung des öffentlichen
Gucker Stephen
Millen White Zelano & Branigan P.C.
Stucker Jeffrey
LandOfFree
Inhibition of the CD95 ligand/receptor system for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of the CD95 ligand/receptor system for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of the CD95 ligand/receptor system for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2631266